Drug Type Small molecule drug |
Synonyms R-7-Cl O-necrostatin-1 |
Target |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | CN | 24 Jan 2023 | |
Central Nervous System Diseases | Preclinical | CN | 24 Jan 2023 |